These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 29847604)
1. Correction: PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines. Dou R; Liu Z; Yuan X; Xiangfei D; Bai R; Bi Z; Yang P; Yang Y; Dong Y; Su W; Li D; Mao C PLoS One; 2018; 13(5):e0198501. PubMed ID: 29847604 [TBL] [Abstract][Full Text] [Related]
2. PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines. Dou R; Liu Z; Yuan X; Xiangfei D; Bai R; Bi Z; Yang P; Yang Y; Dong Y; Su W; Li D; Mao C PLoS One; 2017; 12(5):e0176823. PubMed ID: 28464025 [TBL] [Abstract][Full Text] [Related]
3. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194 [TBL] [Abstract][Full Text] [Related]
4. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway. Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970 [TBL] [Abstract][Full Text] [Related]
5. Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines. Wu Y; Chen X; Ge X; Xia H; Wang Y; Su S; Li W; Yang T; Wei M; Zhang H; Gou L; Li J; Jiang X; Yang J J Mol Med (Berl); 2016 Feb; 94(2):195-206. PubMed ID: 26383911 [TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
8. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis. Irrera N; Vaccaro M; Bitto A; Pallio G; Pizzino G; Lentini M; Arcoraci V; Minutoli L; Scuruchi M; Cutroneo G; Anastasi GP; Ettari R; Squadrito F; Altavilla D Clin Sci (Lond); 2017 Mar; 131(6):487-498. PubMed ID: 28096316 [TBL] [Abstract][Full Text] [Related]
9. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice. Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383 [TBL] [Abstract][Full Text] [Related]
10. Baicalin Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice. Hung CH; Wang CN; Cheng HH; Liao JW; Chen YT; Chao YW; Jiang JL; Lee CC Planta Med; 2018 Oct; 84(15):1110-1117. PubMed ID: 29763944 [TBL] [Abstract][Full Text] [Related]
11. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation. An J; Li Z; Dong Y; Ren J; Huo J Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949 [TBL] [Abstract][Full Text] [Related]
12. NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH. Andrés RM; Montesinos MC; Navalón P; Payá M; Terencio MC J Invest Dermatol; 2013 Oct; 133(10):2362-2371. PubMed ID: 23594598 [TBL] [Abstract][Full Text] [Related]
13. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation. Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402 [TBL] [Abstract][Full Text] [Related]
14. Gold lotion from citrus peel extract ameliorates imiquimod-induced psoriasis-like dermatitis in murine. Lin CC; Wu JJ; Pan YG; Chao YH; Lin FC; Lee YR; Chu CL J Sci Food Agric; 2018 Nov; 98(14):5509-5517. PubMed ID: 29691866 [TBL] [Abstract][Full Text] [Related]
15. Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice. Li P; Li Y; Jiang H; Xu Y; Liu X; Che B; Tang J; Liu G; Tang Y; Zhou W; Zhang L; Dong C; Chen H; Zhang K; Du Z Int Immunopharmacol; 2018 Jun; 59():243-251. PubMed ID: 29665498 [TBL] [Abstract][Full Text] [Related]
16. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells. Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016 [TBL] [Abstract][Full Text] [Related]
17. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin. Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413 [TBL] [Abstract][Full Text] [Related]
18. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model. Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324 [TBL] [Abstract][Full Text] [Related]
19. Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice. Jeon YJ; Sah SK; Yang HS; Lee JH; Shin J; Kim TY Exp Mol Med; 2017 Jun; 49(6):e349. PubMed ID: 28665921 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of cucurbitacin B on imiquimod-induced skin inflammation. Li ZJ; Shin JM; Choi DK; Lim SK; Yoon TJ; Lee YH; Sohn KC; Im M; Lee Y; Seo YJ; Kim CD; Lee JH Biochem Biophys Res Commun; 2015 Apr; 459(4):673-8. PubMed ID: 25767074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]